Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 163

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 163
---
 |                 $ | (7,546,328 | ) |     |    $ | (4,952,223 | ) |
| Dividend on Series A Convertible Preferred Stock, as restated                                                 |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Deemed dividend on extinguishment of Series A Convertible Preferred                                           
 Stock, as restated                                                                                            |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Deemed dividend on modification of equity-classified warrants, as restated                                    |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Deemed contribution on conversion of preferred stock and settlement of preferred stock dividends, as restated |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Net loss attributable to common stockholders                                                                  |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Weighted average common shares outstanding - basic and diluted                                                |     |                    |  2,384,177 |   |     |      |  1,969,904 |   |     |                   |  2,189,366 |   |     |      |  1,820,006 |   |
| Net loss per shares - basic and diluted                                                                       |     |                  $ |      (1.59 | ) |     |    $ |      (0.91 | ) |     |                 $ |      (3.45 | ) |     |    $ |      (2.72 | ) |

<div align='center'>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</div>

| F-3 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

(Unaudited)</div>

For the Nine Months Ended September 30, 2024

|                                                                                       |     | Shares       
 Common Stock 
 Shares       |           |     | Amount 
 Amount |    |     | Capital    
 Additional 
 Paid in